Literature DB >> 9848798

A longitudinal study of blood pressure in relation to performance on the Wechsler Adult Intelligence Scale.

M F Elias1, M A Robbins, P K Elias, D H Streeten.   

Abstract

A growth curve analysis was used to examine estimated longitudinal decline (over 19 years) on the Wechsler Adult Intelligence Scale (WAIS; D. Wechsler, 1955) in relation to arterial hypertension and blood pressure (BP) for 55 men and 85 women (40 to 70 years old) who were free from overt major coexisting diseases. BP was associated with longitudinal decline for Visualization-Performance (VP) ability and Speed. Hypertension was a weaker predictor of VP and was unrelated to Speed. Age effects on VP were overestimated when averaged BP level, particularly systolic BP, was not controlled statistically. It was concluded that initial BP level and hypertension predict age-related longitudinal decline in specific major abilities assessed by the WAIS but that BP averaged over examinations is a stronger predictor.

Entities:  

Mesh:

Year:  1998        PMID: 9848798     DOI: 10.1037//0278-6133.17.6.486

Source DB:  PubMed          Journal:  Health Psychol        ISSN: 0278-6133            Impact factor:   4.267


  12 in total

1.  An evaluation of analytical approaches for understanding change in cognition in the context of aging and health.

Authors:  Andrea M Piccinin; Graciela Muniz; Catharine Sparks; Daniel E Bontempo
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2011-07       Impact factor: 4.077

2.  Diastolic Blood Pressure, Not Just Systolic Blood Pressure, Is Related to Cerebral Measures in Middle Age: Implications for Prospective Studies.

Authors:  Merrill F Elias; Rachael V Torres; Adam Davey
Journal:  Am J Hypertens       Date:  2018-11-13       Impact factor: 2.689

3.  Effects of hypertension and diabetes on sentence comprehension in aging.

Authors:  Dalia Cahana-Amitay; Martin L Albert; Emmanuel A Ojo; Jesse Sayers; Mira Goral; Loraine K Obler; Avron Spiro
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2012-10-09       Impact factor: 4.077

4.  Blood Pressure Variability and Cognitive Function Among Older African Americans: Introducing a New Blood Pressure Variability Measure.

Authors:  Siny Tsang; Scott A Sperling; Moon Ho Park; Ira M Helenius; Ishan C Williams; Carol Manning
Journal:  Cogn Behav Neurol       Date:  2017-09       Impact factor: 1.600

Review 5.  Clinical Trials of Blood Pressure Lowering and Antihypertensive Medication: Is Cognitive Measurement State-of-the-Art?

Authors:  Merrill F Elias; Rachael V Torres; Adam Davey
Journal:  Am J Hypertens       Date:  2018-05-07       Impact factor: 2.689

6.  Decline in renal functioning is associated with longitudinal decline in global cognitive functioning, abstract reasoning and verbal memory.

Authors:  Adam Davey; Merrill F Elias; Michael A Robbins; Stephen L Seliger; Gregory A Dore
Journal:  Nephrol Dial Transplant       Date:  2012-11-18       Impact factor: 5.992

7.  Effects of health status on word finding in aging.

Authors:  Martin L Albert; Avron Spiro; Keely J Sayers; Jason A Cohen; Christopher B Brady; Mira Goral; Loraine K Obler
Journal:  J Am Geriatr Soc       Date:  2009-12       Impact factor: 5.562

8.  [Effects of long-term antihypertensive therapy with losartan on blood pressure and cognitive function in patients with essential hypertension and other cerebrovascular risk factors (AWARE observational study)].

Authors:  Jürgen Schrader; Stephan Lüders; Hans-Christoph Diener; Hermann Haller; Roland E Schmieder; Klaus Wahle; Wenefrieda Smolka; Claudia Jung; Kurt Bestehorn
Journal:  Med Klin (Munich)       Date:  2008-07-15

9.  Cognitive efficiency declines over time in adults with Type 1 diabetes: effects of micro- and macrovascular complications.

Authors:  C M Ryan; M O Geckle; T J Orchard
Journal:  Diabetologia       Date:  2003-06-18       Impact factor: 10.122

10.  High blood pressure and cognitive decline in mild cognitive impairment.

Authors:  Felicia C Goldstein; Allan I Levey; N Kyle Steenland
Journal:  J Am Geriatr Soc       Date:  2013-01-10       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.